SARTORIUS AG (SRT.DE) Stock Fundamental Analysis
Europe - FRA:SRT - DE0007165607 - Common Stock
183.2 EUR
-7.2 (-3.78%)
Overall SRT gets a fundamental rating of 3 out of 10. We evaluated SRT against 18 industry peers in the Life Sciences Tools & Services industry. SRT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, SRT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
SRT had positive earnings in the past year.
In the past year SRT had a positive cash flow from operations.
SRT had positive earnings in each of the past 5 years.
Each year in the past 5 years SRT had a positive operating cash flow.
1.2 Ratios
The Return On Assets of SRT (1.39%) is worse than 77.78% of its industry peers.
SRT has a Return On Equity of 5.01%. This is in the lower half of the industry: SRT underperforms 72.22% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.71%, SRT is doing worse than 72.22% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SRT is in line with the industry average of 7.57%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
Looking at the Profit Margin, with a value of 3.80%, SRT is doing worse than 77.78% of the companies in the same industry.
SRT's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 14.06%, SRT is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
SRT's Operating Margin has declined in the last couple of years.
The Gross Margin of SRT (46.48%) is better than 77.78% of its industry peers.
In the last couple of years the Gross Margin of SRT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
SRT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SRT has been increased compared to 1 year ago.
SRT has more shares outstanding than it did 5 years ago.
SRT has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.10 indicates that SRT is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SRT (2.10) is worse than 66.67% of its industry peers.
SRT has a debt to FCF ratio of 8.92. This is a slightly negative value and a sign of low solvency as SRT would need 8.92 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.92, SRT is doing worse than 61.11% of the companies in the same industry.
A Debt/Equity ratio of 1.28 is on the high side and indicates that SRT has dependencies on debt financing.
The Debt to Equity ratio of SRT (1.28) is worse than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.1 |
ROIC/WACC0.63
WACC7.53%
2.3 Liquidity
A Current Ratio of 0.95 indicates that SRT may have some problems paying its short term obligations.
SRT has a Current ratio of 0.95. This is amonst the worse of the industry: SRT underperforms 83.33% of its industry peers.
SRT has a Quick Ratio of 0.95. This is a bad value and indicates that SRT is not financially healthy enough and could expect problems in meeting its short term obligations.
SRT has a Quick ratio of 0.49. This is amonst the worse of the industry: SRT underperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
SRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.34%, which is quite impressive.
The earnings per share for SRT have been decreasing by -11.87% on average. This is quite bad
The Revenue has been growing slightly by 5.82% in the past year.
Measured over the past years, SRT shows a quite strong growth in Revenue. The Revenue has been growing by 13.10% on average per year.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
Based on estimates for the next years, SRT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.16% on average per year.
Based on estimates for the next years, SRT will show a quite strong growth in Revenue. The Revenue will grow by 8.92% on average per year.
EPS Next Y23.27%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
EPS Next 5Y19.16%
Revenue Next Year5.14%
Revenue Next 2Y7.17%
Revenue Next 3Y8.54%
Revenue Next 5Y8.92%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 40.18, SRT can be considered very expensive at the moment.
Based on the Price/Earnings ratio, SRT is valued a bit more expensive than the industry average as 72.22% of the companies are valued more cheaply.
SRT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.51.
A Price/Forward Earnings ratio of 30.74 indicates a quite expensive valuation of SRT.
66.67% of the companies in the same industry are cheaper than SRT, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.53. SRT is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.18 | ||
| Fwd PE | 30.74 |
4.2 Price Multiples
SRT's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRT indicates a somewhat cheap valuation: SRT is cheaper than 66.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.66 | ||
| EV/EBITDA | 19.56 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as SRT's earnings are expected to grow with 22.38% in the coming years.
PEG (NY)1.73
PEG (5Y)N/A
EPS Next 2Y20.61%
EPS Next 3Y22.38%
5. Dividend
5.1 Amount
SRT has a yearly dividend return of 0.39%, which is pretty low.
Compared to an average industry Dividend Yield of 0.72, SRT has a dividend in line with its industry peers.
With a Dividend Yield of 0.39, SRT pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
5.2 History
The dividend of SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
SRT pays out 37.92% of its income as dividend. This is a sustainable payout ratio.
The dividend of SRT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP37.92%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
FRA:SRT (11/3/2025, 7:00:00 PM)
183.2
-7.2 (-3.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.72B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target269.28 (46.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.45%
PT rev (3m)-7.37%
EPS NQ rev (1m)3.45%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)0%
EPS NY rev (3m)0.3%
Revenue NQ rev (1m)2.71%
Revenue NQ rev (3m)2.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.18 | ||
| Fwd PE | 30.74 | ||
| P/S | 3.9 | ||
| P/FCF | 28.66 | ||
| P/OCF | 15.69 | ||
| P/B | 5.14 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.56 |
EPS(TTM)4.56
EY2.49%
EPS(NY)5.96
Fwd EY3.25%
FCF(TTM)6.39
FCFY3.49%
OCF(TTM)11.68
OCFY6.37%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)1.73
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.1 |
F-Score7
WACC7.53%
ROIC/WACC0.63
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y23.27%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
EPS Next 5Y19.16%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.14%
Revenue Next 2Y7.17%
Revenue Next 3Y8.54%
Revenue Next 5Y8.92%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year99.69%
EBIT Next 3Y38.21%
EBIT Next 5Y26.49%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG / SRT.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG (SRT.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT.DE.
Can you provide the valuation status for SARTORIUS AG?
ChartMill assigns a valuation rating of 2 / 10 to SARTORIUS AG (SRT.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG?
SARTORIUS AG (SRT.DE) has a profitability rating of 3 / 10.
What is the expected EPS growth for SARTORIUS AG (SRT.DE) stock?
The Earnings per Share (EPS) of SARTORIUS AG (SRT.DE) is expected to grow by 23.27% in the next year.
Can you provide the dividend sustainability for SRT stock?
The dividend rating of SARTORIUS AG (SRT.DE) is 4 / 10 and the dividend payout ratio is 37.92%.